Long-acting Buprenorphine Treatment for Opioid Use Disorder

February 11, 2020

Loading Events
  • This event has passed.
Watch Now View Presentation Slides

Presenter(s): Michelle Lofwall, MD, DFASAM, University of Kentucky Medicine

Cost: No fee

Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, pharmacists, social workers, and healthcare teams.

Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, CEUs for psychology, SW CE credit, Interprofessional Continuing Education (IPCE) credit, and Pharmacy Continuing Education Credit.

Educational Objectives: To identify the FDA indications for long-acting buprenorphine implants and subcutaneous injections, to explain the storage requirements for long-acting buprenorphine formulations, and to compare the potential advantages and disadvantages of these new formulations in patient care.

Webinar Description: Lack of knowledge about available long-acting buprenorphine formulations has led their under-utilization in the health care system, despite large unmet treatment needs among those with opioid use disorder. A multi-disciplinary approach that includes the collaboration between nurse practitioners, PAs, physicians, psychologists, social workers and hospital administrators is necessary to address this gap in knowledge and provide evidence-based care to those with opioid use disorder. Several newly approved long-acting buprenorphine formulations give patients and providers new options to consider. This webinar will review the peer-reviewed publications from three FDA-approved long-acting products, their FDA-approved indications, practical information on how to use them in clinical practice, ongoing NIDA clinical trials employing these long-acting medications, and patient case scenarios.

Accreditation and Certification of this activity

Jointly Accredited Provider Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by American Academy of Addiction Psychiatry (AAAP) and American Psychiatric Association (APA). AAAP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

In 2020, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA), Association for Social Work Boards (ASWB) and American Dental Association (ADA).

IPCE Credit Interprofessional Continuing Education (IPCE) Designation Statement

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 Nursing Contact Hours.

PA AAPA Category 1 CME PA Designation Statement

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Psychological AssociationPsychologist Designation Statement

Continuing Education (CE) credits for psychologists are provided through AAAP’s Joint Accreditation provider #4008192. This activity is approved for 1 CEU hours.

Approved Continuing Education Social Work Designation Statement

As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credit.

Pharmacy Designation Statement

This course has been approved for 1 hour of pharmacy continuing education credit. The approval number issued is Universal Activity Number: UAN JA4008192-9999-20-002-H01-P (pharmacy).

Details

Date:
February 11
Time:
12:00 pm - 1:00 pm
Event Category:

Other

Presenter
Michelle Lofwall, MD, DFASAM, University of Kentucky Medicine
Time Zone
ET